Capex / revenue moved 285 bp lower
Capex / revenue changed -285 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
7.99%→5.14%4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →KLXE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure decreased 32.3%
Capital expenditure changed -32.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$12.7M→$8.6M4 prior comparisons
Cash & equivalents decreased 52.7%
Cash & equivalents changed -52.7% from the comparable as-filed period.
$16.7M→$7.9M2 prior comparisons
Debt increased 11.7%
Debt changed +11.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$258.7M→$288.9M4 prior comparisons
Net income increased 57.8%
Net income changed +57.8% from the comparable as-filed period.
-$19.9M→-$8.4M3 prior comparisons
Operating income increased 124.1%
Operating income changed +124.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-$8.7M→$2.1M4 prior comparisons
Operating margin moved 673 bp higher
Operating margin changed +673 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-5.47%→1.26%4 prior comparisons
Research & development increased 25.0%
Research & development changed +25.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$400,000→$500,0004 prior comparisons
Revenue increased 5.2%
Revenue changed +5.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$159.0M→$167.3M4 prior comparisons
Selling, general & administrative increased 5.6%
Selling, general & administrative changed +5.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$18.0M→$19.0M4 prior comparisons
Inventory unchangedd 0.0%
Inventory changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$32.0M→$32.0M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.